Transplantation pathology

Seminars in Diagnostic Pathology

Volumn 23, Issue 3-4, 2006, Pages 170-181

  Hübscher, Stefan G ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Chronic hepatitis; De novo disease; Liver allograft rejection; Liver transplantation; Preservation reperfusion injury; Recurrent disease

Indexed keywords

ACUTE GRAFT REJECTION; ARTICLE; AUTOIMMUNE HEPATITIS; BILIARY TRACT DISEASE; BLOOD VESSEL SHUNT; CHRONIC GRAFT REJECTION; CHRONIC HEPATITIS; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; GOLD STANDARD; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; OPPORTUNISTIC INFECTION; ORGAN PRESERVATION; POSTOPERATIVE COMPLICATION; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; REPERFUSION; REPERFUSION INJURY; SYSTEMATIC REVIEW; VASCULAR DISEASE;

GRAFT REJECTION; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION;

EID: 33846574765     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2006.11.004     Document Type: Article

References (20)

1. Hubscher S.G., and Portmann B.C. Transplantation pathology. In: Burt A.D., Portmann B.C., and Ferrell L.D. (Eds). MacSween's Pathology of the Liver (2006), Churchill Livingstone, Edinburgh 815-879
2. Tran T.T., Changsri C., Shackleton C.R., et al. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. J Gastroenterol Hepatol 21 (2006) 381-383
3. Pungpapong S., Krishna M., Abraham S.C., et al. Clinicopathologic findings and outcomes of liver transplantation using grafts from donors with unrecognized and unusual diseases. Liver Transpl 12 (2006) 310-315
4. Usuda M., Fujimori K., Koyamada N., et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation. Transplantation 79 (2005) 12-16
5. Haga H., Egawa H., Fujimoto Y., et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl 12 (2006) 457-464
6. Dankof A., Schmeding M., Morawietz L., et al. Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection. Virchows Arch 447 (2005) 87-93
7. Schmeding M., Dankof A., Krenn V., et al. C4d in acute rejection after liver transplantation: a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant 6 (2006) 523-530
8. Neuman U.P., and Neuhaus P.C. C4d immunostaining in acute humoral rejection after ABO blood group-incompatible liver transplantation. Liver Transpl 12 (2006) 356-357
9. Demetris A.J., Adeyi O., Bellamy C.O., et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 44 (2006) 489-501
10. Sundaram S.S., Melin-Aldana H., Neighbors K., et al. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients. Liver Transpl 12 (2006) 58-64
11. International Panel. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25 (1997) 658-663
12. Demetris A., Adams D., Bellamy C., et al., An International Panel. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. Hepatology 31 (2000) 792-799
13. Demetris A.J., Kelly D.M., Eghtesad B., et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol 30 (2006) 986-993
14. Krishna M., Keaveny A.P., Genco P.V., et al. Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis. Transplant Proc 37 (2005) 2221-2223
15. Hubscher S.G. Recurrent and de-novo disease in the liver allograft. Curr Opin Organ Transplant 11 (2006) 283-288
16. Demetris A.J., Eghtesad B., Marcos A., et al. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol 28 (2004) 658-669
17. Regev A., Molina E., Moura R., et al. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl 10 (2004) 1233-1239
18. Riva S., Sonzogni A., Bravi M., et al. Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience. Liver Transpl 12 (2006) 573-577
19. Neuberger J. Chronic allograft dysfunction: diagnosis and management. Is it always progressive?. Liver Transpl 11 (2005) S63-S68
20. Evans H.M., Kelly D.A., McKiernan P.J., et al. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 43 (2006) 1109-1117